A Prime Ministerial Push and the Path Ahead, Can India Turn the Tide on Antimicrobial Resistance?

A Prime Ministerial Push and the Path Ahead, Can India Turn the Tide on Antimicrobial Resistance?

Introduction: A Watershed Moment in Public Health Communication

On December 28, 2025, in his 129th and final Mann Ki Baat broadcast of the year, Prime Minister Narendra Modi did something unprecedented in the history of India’s public health discourse. He brought the complex, creeping crisis of Antimicrobial Resistance (AMR) directly into the living rooms, cars, and mobile phones of millions of citizens. By naming it a “matter of concern for us,” quoting alarming data from the Indian Council of Medical Research (ICMR), and directly linking it to the “thoughtless and indiscriminate use of antibiotics by people,” the Prime Minister performed a vital act of mainstreaming. He elevated AMR from the specialised corridors of infectious disease departments and policy white papers to the realm of dinner-table conversation and public consciousness. This moment is potentially the single most significant awareness-raising intervention in India’s battle against AMR, a battle that will define the country’s health security and economic stability for decades to come. However, as the article by Ramya Kannan insightfully argues, while this clarion call from the highest pulpit is a necessary and powerful signal, it is merely the opening salvo. To truly sharpen India’s AMR battle, this signal must be fine-tuned into a symphony of coordinated, well-funded, and rigorously enforced actions across human, animal, and environmental health.

The Stark Reality of AMR in India: A Silent Pandemic

Antimicrobial Resistance occurs when bacteria, viruses, fungi, and parasites evolve to defeat the drugs designed to kill them. The result is that common infections become untreatable, routine surgeries and cancer chemotherapy become high-risk procedures, and the foundational pillars of modern medicine crumble. India, with its massive population, high burden of infectious diseases, intensive agricultural and livestock practices, and largely unregulated over-the-counter sale of antibiotics, is a global epicentre of this crisis. The ICMR’s annual reports paint a grim picture: rising resistance in pathogens causing pneumonia, bloodstream infections, urinary tract infections, and surgical site infections. Key last-resort antibiotics are losing their efficacy at an alarming rate.

The drivers are multifaceted but converge on one central problem: the rampant misuse and overuse of antimicrobials. In human health, this includes patients demanding antibiotics for viral infections like the common cold, doctors prescribing them empirically without confirmatory tests due to time constraints or patient pressure, and the pervasive culture of self-medication enabled by easy access at pharmacies. In the animal sector, antibiotics are used liberally as growth promoters and for prophylactic purposes in crowded, unsanitary farms, a practice ostensibly banned for certain critical drugs like colistin but poorly enforced. In the environment, pharmaceutical effluent and unmetabolized antibiotics excreted by humans and animals seep into water and soil, creating breeding grounds for resistant genes.

PM Modi’s address brilliantly zeroed in on the most visible and addressable component for the public: the casual, self-prescribing citizen. His admonition — “Avoid taking medicines by yourself, particularly antibiotics” — is a simple, actionable message. By framing it as a matter of personal and national responsibility, he has the potential to shift social norms. Past initiatives, such as the 2017 National Action Plan on AMR (NAP-AMR) and the 2019 ban on colistin in animal feed, were crucial policy steps but lacked the mass mobilisation component. The Mann Ki Baat address supplies that missing element: a direct, authoritative, and widely disseminated public health advisory from the country’s most influential figure.

Beyond Awareness: The Imperative for a Robust “One Health” Surveillance Network

While awareness is the indispensable first step, it is insufficient alone. As Kannan’s article underscores, India’s fight is hobbled by a critical data deficit. You cannot manage what you cannot measure. India’s National AMR Surveillance Network (NARS-Net), established in 2019 and feeding into the WHO’s GLASS system, is a commendable start. However, with only 41-60 sentinel sites reporting from largely urban, tertiary-care government medical colleges, it presents a skewed, incomplete picture of the national AMR landscape.

This urban-tertiary bias is a profound limitation. It ignores the reality of healthcare delivery in India, where a vast majority seek treatment first in private clinics, secondary care hospitals, and primary health centres in semi-urban and rural areas. These settings often have different prescription practices, patient demographics, and infection profiles. The resistance patterns brewing in a community health centre in rural Bihar or a private nursing home in a Tier-3 town are likely very different from those in an apex hospital in Delhi or Chennai. By not capturing this data, NARS-Net risks creating a statistical mirage—a national average that underestimates the true scale and geographical heterogeneity of the problem. As Dr. Abdul Ghafur argues in his letter to the National Centre for Disease Control (NCDC), “the only credible approach is to present true national data… inclusive of secondary and primary care centres.”

The prescription, therefore, is a massive, strategic expansion of the surveillance network. This must be a multi-pronged effort:

1. Geographical and Sectoral Expansion: Hundreds of new surveillance nodes must be established in district hospitals, community health centres, and private hospitals across all states. Private sector inclusion is non-negotiable, given its dominant share in healthcare provision. This requires creating standardised protocols, providing training and resources, and building trust through collaborative frameworks.

2. Embracing the “One Health” Mandate in Data Collection: Surveillance cannot be confined to human hospitals. It must be integrated with parallel systems in animal husbandry (monitoring resistance in livestock and poultry pathogens) and environmental science (testing water bodies, soil, and sewage for resistant genes and antibiotics). The interconnections are direct: resistant bacteria from farms enter the food chain and environment; environmental contamination cycles them back to humans. A siloed human-health-only dataset is functionally blind to half the problem.

3. Leveraging Technology and Real-Time Data: The expanded network should be powered by digital health platforms that allow for real-time or near-real-time data entry and analysis. This would enable the early detection of emerging resistance hotspots and superbugs, allowing for swift, targeted public health responses, rather than the current model of retrospective annual reports.

The Policy and Enforcement Chasm: From Plan to Action

The 2017 NAP-AMR outlines a comprehensive “One Health” strategy across six pillars: awareness, surveillance, infection prevention, antimicrobial stewardship, research, and international collaboration. PM Modi’s speech powerfully addresses Pillar 1 (awareness). However, the other pillars suffer from chronic under-resourcing, weak inter-ministerial coordination, and a vast enforcement gap.

• Infection Prevention and Control (IPC): Basic IPC practices—hand hygiene, sterile techniques, hospital waste management—are the first line of defense against the spread of resistant infections in healthcare settings. Yet, compliance is patchy even in large hospitals, and critically lacking in smaller nursing homes and clinics. Strengthening IPC requires not just guidelines but mandatory accreditation, regular audits, and significant investment in hospital infrastructure (like clean water, sanitation, and isolation facilities).

• Antimicrobial Stewardship Programs (AMSP): These are institutional programs to optimize antibiotic use in hospitals. While some large corporate and public hospitals have them, they are absent in the vast majority of healthcare facilities. Making AMSPs mandatory and providing the necessary clinical pharmacologists, microbiologists, and data support is essential.

• Regulating the Animal Sector: The ban on colistin as a growth promoter is a landmark, but its on-ground enforcement is questionable. A broader, phased withdrawal of all antibiotic growth promoters, coupled with the promotion of alternatives (probiotics, better farm management) and strict veterinary oversight of therapeutic antibiotic use, is needed.

• Curbing Over-the-Counter Sales: This is perhaps the most challenging yet crucial frontier. Despite regulations, antibiotics are widely sold without prescription. Fixing this requires a multi-stakeholder approach: empowering and holding pharmacists accountable, using technology (e-prescriptions), running public campaigns to empower patients to refuse unprescribed antibiotics, and implementing strong deterrent penalties for violators.

Conclusion: Fine-Tuning the Signal into a Sustained Symphony

Prime Minister Modi’s Mann Ki Baat address on AMR is a historic and welcome inflection point. It has the potential to catalyse a societal movement, changing the “pop-a-pill” culture that fuels this crisis. For that potential to be realised, the powerful signal he sent must not be allowed to fade into static. It must be fine-tuned and amplified into a sustained, multi-sectoral national mission.

This requires moving from rhetoric to rigorous implementation. It demands that the political will demonstrated in the broadcast be translated into budgetary allocations for surveillance expansion, IPC, and stewardship. It necessitates breaking down the silos between the Ministry of Health, Ministry of Fisheries, Animal Husbandry & Dairying, Ministry of Environment, and the state governments to operationalise the “One Health” approach in letter and spirit. It calls for empowering regulators and holding all actors—doctors, pharmacists, veterinarians, farmers, and patients—accountable.

The battle against AMR is a marathon, not a sprint. It is a fight against an invisible, adaptive enemy that thrives on our complacency and fragmentation. PM Modi has, with one speech, fired the starting gun and rallied the nation’s attention. The race ahead is long and arduous. Whether India wins will depend on whether this moment of mainstream awareness is swiftly followed by the unglamorous, technical, and determined work of building systems, generating representative data, enforcing laws, and fostering a culture of responsible antimicrobial use across all sectors. The time for that work is now.

Q&A Section

Q1: Why is Prime Minister Modi’s mention of AMR in Mann Ki Baat considered a potential game-changer, compared to earlier policy initiatives?
A1: Earlier initiatives like the National Action Plan on AMR (2017) were crucial policy frameworks but largely remained within bureaucratic and medical circles. Prime Minister Modi’s address directly targeted the public, leveraging his unparalleled mass communication platform. By simplifying the complex issue into a clear message about avoiding self-medication with antibiotics, he translated a scientific warning into a public health directive with the highest possible authority. This mainstreaming has the unique potential to shift societal behaviour and norms on a massive scale, creating a bottom-up demand for responsible antibiotic use that top-down policies alone could never achieve.

Q2: What is the critical flaw in India’s current AMR surveillance system (NARS-Net), and what are its implications?
A2: The critical flaw is its severe urban and tertiary-care bias. NARS-Net primarily collects data from sentinel sites in major government medical colleges in cities. This fails to capture the AMR trends in the places where most Indians first seek care: private clinics, secondary hospitals, and primary health centres in semi-urban and rural areas. The implication is a distorted, incomplete national picture. We may be underestimating the true prevalence and missing unique resistance patterns emerging in non-urban settings, leading to poorly targeted interventions and a false sense of security about the overall crisis.

Q3: What does a “One Health” approach to AMR surveillance entail, and why is it essential for India?
A3: A “One Health” approach recognizes that the health of humans, animals, and the environment is interconnected. For AMR surveillance, this means moving beyond just human hospitals. It entails:

• Human Health: Expanding surveillance to diverse healthcare settings.

• Animal Health: Systematically monitoring antibiotic use and resistance in livestock, poultry, and aquaculture.

• Environmental Health: Testing wastewater, rivers, soil, and food products for antibiotic residues and resistant genes.
  It is essential because resistant bacteria and genes move freely across these domains. Antibiotics used in farms end up in the environment and food chain, driving resistance in human pathogens. Without integrated surveillance, we are only seeing part of the cycle and cannot design effective, holistic interventions to break it.

Q4: Beyond public awareness, what are the key areas where policy enforcement is currently failing in India’s AMR battle?
A4: Key enforcement gaps exist in several areas:

• Pharmacy Regulation: Despite laws, over-the-counter sale of antibiotics without a prescription is rampant, with little deterrent penalty for pharmacists.

• Animal Agriculture: The ban on colistin and other antibiotics as growth promoters is poorly enforced at the farm level due to a lack of monitoring and readily available alternatives.

• Infection Control in Healthcare: Basic infection prevention and control (IPC) protocols are not uniformly implemented or audited, especially in smaller private facilities, facilitating the spread of resistant infections.

• Antimicrobial Stewardship: Few hospitals, outside major urban centres, have active programs to audit and optimize antibiotic prescriptions by doctors. These systemic enforcement failures undermine the impact of even the best awareness campaigns.

Q5: How can the momentum from the Prime Minister’s speech be concretely translated into actionable progress on the ground?
A5: Concrete translation requires immediate, coordinated action on multiple fronts:

1. Surveillance Investment: The government must allocate significant funds to rapidly scale up NARS-Net to include a representative network of private and public primary/secondary care centres and establish parallel surveillance in animal and environmental sectors.

2. Inter-Ministerial Task Force: Create a high-powered, accountable task force with representatives from all relevant ministries (Health, Animal Husbandry, Environment, Chemicals) to ensure the “One Health” NAP-AMR is implemented cohesively.

3. Strengthening Regulations: Launch a national drive to enforce prescription-only antibiotic sales, with technology (e-prescriptions) and strict penalties. Simultaneously, ramp up inspections in the animal feed and pharmaceutical manufacturing sectors.

4. Capacity Building: Train a cadre of professionals—microbiologists, pharmacists, veterinarians—in AMR stewardship and surveillance across the country.

5. Sustained Public Campaign: Follow up the PM’s speech with a relentless, multi-lingual public campaign using various media to reinforce the “no self-medication” message and educate on the “One Health” link (e.g., how farm antibiotic use affects human health).